Notes from the field: emergency department visits and hospitalizations for buprenorphine ingestion by children – United States, 2010-2011.

Posted on by

Authors: Centers for Disease Control and Prevention (CDC)
Abstract
Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to reduce the morbidity and mortality associated with opioid abuse, and buprenorphine has become an increasingly prescribed component of office-based treatment. However, unsupervised ingestion of buprenorphine-containing products by children is a growing concern.
PMID: 23344700 [PubMed – in process] (Source: MMWR Morb Mortal Wkl…)